Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?

  • Jien Jiun Chen
  • , Lian Yu Lin
  • , Yao Hsu Yang
  • , Juey Jen Hwang
  • , Pau Chung Chen*
  • , Jiunn Lee Lin
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)53
Number of pages1
JournalInternational Journal of Cardiology
Volume196
DOIs
StatePublished - 23 07 2015
Externally publishedYes

Keywords

  • Aspirin stroke
  • Atrial fibrillation
  • Coumadin
  • End-stage renal disease

Cite this